enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Macmillan Cancer Support - Wikipedia

   en.wikipedia.org/wiki/Macmillan_Cancer_Support

   Macmillan Cancer Support merged with cancer information charity Cancerbackup in 2008. Macmillan works in partnership with other cancer research organisations and is a partner of the National Cancer Research Institute. Macmillan is part of the Richmond Group of Charities, which is a coalition of 14 leading health and social care organisations in ...

3. Bladder Cancer and Medicare: What’s Covered and What’s Not?

   www.aol.com/bladder-cancer-medicare-covered-not...

   Medicare may cover some costs for bladder cancer treatment. Talk to your doctor to confirm coverage and to learn about other options you may have. ... For premium support please call: 800-290-4726 ...

4. Bladder cancer - Wikipedia

   en.wikipedia.org/wiki/Bladder_cancer

   Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2] This makes bladder cancer the sixth most common cancer in men, and the seventeenth in women. [57] When women are diagnosed with bladder cancer, they tend to have more advanced disease and consequently a poorer prognosis. [57]

5. Gemcitabine - Wikipedia

   en.wikipedia.org/wiki/Gemcitabine

   Gemcitabine, sold under the brand name Gemzar, among others, [1] is a chemotherapy medication used to treat cancers. [2] It is used to treat testicular cancer, [3] breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.

6. Ifosfamide - Wikipedia

   en.wikipedia.org/wiki/Ifosfamide

   Ifosfamide (IFO), sold under the brand name Ifex among others, is a chemotherapy medication used to treat a number of types of cancer. [2] This includes testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, cervical cancer, and ovarian cancer. [2] It is administered by injection into a vein. [2]

7. US FDA approves ImmunityBio's bladder cancer therapy - AOL

   www.aol.com/news/u-fda-approves-immunitybios...

   (Reuters) -The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder cancer, marking an end to the company's efforts to bring its therapy to the market.